Inventor · disambiguated record
Shuang Zhao
Also filed as: ZHAO SHUANG · ZHAO SHUANG G
5 granted patents·12 pending applications·3 citations·filing 2010–2024
64Inventor score
Files withWISCONSIN ALUMNI RES FOUND4VERACYTE SD INC3DECIPHER BIOSCIENCES INC2UNIV MICHIGAN2BIODURO BEIJING CO LTD1
Top patents by PatentIndex Score
17 records- 0182US11414708B2Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapyDECIPHER BIOSCIENCES INC·Filed 2017·Granted Aug 16, 2022·3 cites·9 claims
- 0271US2024096447A1Methods of generating phenocopy signatures and uses thereofWISCONSIN ALUMNI RES FOUND·Filed 2023·Application pending·0 cites
- 0369US2023386602A1Methods of generating phenocopy signatures and uses thereofWISCONSIN ALUMNI RES FOUND·Filed 2023·Application pending·0 cites
- 0468US2024360517A1Subtyping prostate cancer to predict response to hormone therapyVERACYTE SD INC·Filed 2024·Application pending·0 cites
- 0567US2024145038A1cfDNA FRAGMENTOMIC DETECTION OF CANCERWISCONSIN ALUMNI RES FOUND·Filed 2023·Application pending·0 cites
- 0667US2024096469A1Methods of predicting responses to disease treatmentsWISCONSIN ALUMNI RES FOUND·Filed 2023·Application pending·0 cites
- 0762US2023151429A1Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapyVERACYTE SD INC·Filed 2022·Application pending·0 cites
- 0856US11667616B2Oral GSNOR inhibitor and pharmaceutical use thereofUNIV NANJING MEDICAL·Filed 2021·Granted Jun 6, 2023·0 cites·2 claims
- 0954US11879015B2Antibodies or antigen-binding fragments that bind to OX40BIODURO BEIJING CO LTD·Filed 2022·Granted Jan 23, 2024·0 cites·10 claims
- 1053US11873532B2Subtyping prostate cancer to predict response to hormone therapyVERACYTE SD INC·Filed 2018·Granted Jan 16, 2024·0 cites·10 claims
- 1146US2010198614A1Medical communication system for health care practitionersUNIV MICHIGAN·Filed 2010·Application pending·0 cites
- 1246US2021283089A1Use of fumaric acid esters and pharmaceutically acceptable salts thereof in preparing pharmaceuticals for treating ferroptosis-related diseasesXIANGYA HOSPITAL CENTRAL SOUTH UNIV·Filed 2021·Application pending·0 cites
- 1345US12497660B2Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapyDECIPHER BIOSCIENCES INC·Filed 2018·Granted Dec 16, 2025·0 cites·19 claims
- 1445US2021317535A1Methods of determining treatment consisting of radiation therapy and/or alkylating chemotherapy in patients suffering from cancerUNIV MICHIGAN REGENTS·Filed 2019·Application pending·0 cites
- 1540US2015232931A1Compositions and methods for the analysis of radiosensitivityUNIV MICHIGAN·Filed 2014·Application pending·0 cites
- 1638US2018369241A1Treatment of cancer with dnapk inhibitorsCELGENE CORP·Filed 2016·Application pending·0 cites
- 1735US2018172669A1Screening and use of piperidino pyrazolopyrimidine compoundINST BASIC MEDICAL SCIENCES CAMS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuang Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →